EGFR and lung cancer: Phage display screening with panitumumab-isolated EGFR mimotopes (P19 and P26) and HSP70-P19/P26 fusion proteins reduced tumor growth in lung cancer models, indicating their potential for anti-EGFR immunotherapy [151].